Trial Profile
A Pilot Study of Flavopiridol in Patients With Advanced Solid Tumors.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Biomarker; Pharmacogenomic
- 28 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Nov 2007 Status change from suspended to recruiting